课题基金 / 基金详情

MECHANISMS OF CARDIOMYOCYTE CELL DEATH BY APOPTOSIS

MECHANISMS OF CARDIOMYOCYTE CELL DEATH BY APOPTOSIS
心肌细胞凋亡的机制
批准号:
6288762
负责人:
MICHAEL T CROW
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

MICHAEL T CROW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY OF WORK Cardiac cell loss occurs in response to acute ischemic injury, during heart failure, and during the normal aging of the heart. Cell loss is due predominantly to the death of cardiac myocytes and is mediated in large part by apoptosis and the activation of cysteine proteases known as caspases. We have shown that heart and skeletal muscle contain a specific inhibitor of caspases 2 and 8, known as ARC, and that ARC expression is dramatically reduced during ischemic stress both in cultured myocytes and the intact heart. Furthermore, overexpression of ARC in a heart myogenic cell line protects it from ischemia-induced cell death. Protection is associated with inhibition of caspase 2 activation and cytochrome c release, which occurs in a caspase-independent manner. We have also shown that various growth and neurohormonal factors also provide cardiomyocytes protection from ischemia-induced cell death through ARC-independent pathways. The common element in all such factors is their ability to activate phosphatidylinositol 3-kinase (PI-3K) activity, either directly through recruitment of PI-3K subunits to receptor docking sites (IGF-1) or through Gi-dependent signaling, such as that associated with the beta2- adrenergic receptor. Accordingly, inhibitors of PI-3K block the protective effects of the various survival factors. Current studies are focussed on assessing the role of NF-kB and the Forkhead transcription factors as possible downstream targets of PI-3K activation involved in cell survival. - Cardiomyocytes, Apoptosis, Ischemia, Hypoxia, Adrenergic Signaling, ARC
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determinants of Right Heart Failure In Severe PAH
  • 批准号:
    8013840
  • 项目类别:
  • 资助金额:
    $40.7万
  • 财政年份:
    2010
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
Core--Molecular resources
  • 批准号:
    7347549
  • 项目类别:
  • 资助金额:
    $27.1万
  • 财政年份:
    2007
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
Determinants of Right Heart Failure In Severe PAH
  • 批准号:
    7231194
  • 项目类别:
  • 资助金额:
    $42.14万
  • 财政年份:
    2006
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
ARC REGULATES MITOCHONDRIAL DEATH SIGNALING IN HEART
  • 批准号:
    7093496
  • 项目类别:
  • 资助金额:
    $39.91万
  • 财政年份:
    2004
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: